In partnership with

Expand Your Expertise In Vaccines, Cell, Gene,
Antibody, and RNA Therapies.

Biopharma’s inspiration for the development of targeted biologics is our own human immune system, so we begin with an in-depth explanation of immunology. The course then focuses on the science, challenges, and medical promise of next generation targeted biologics. BioBasics 201 is designed for the non-scientist who has taken BioBasics 101 or for those who understand the basics of DNA, RNA, proteins, and cell signaling. Taught by industry experts who explain how these complex drugs work in a simple, engaging manner.

Discussion points:

• Vaccines
• Cell Therapies
• Gene Therapies
• Antibody Therapeutics
• RNA Therapies

Fierce readers receive $100 off with FIERCE100 code.

Register today! This class will sell out.

Included in the course

• Electronic course workbook
• Access to course recording for 2 weeks
• Course certificate
• Ability to list course on LinkedIn education profile
• Glossary of top biotech terminology

Recorded BioBasics 201:
Targeted Biologics for the Non-Scientist Master course

On-Demand, Online

Biotech Primer has been delivering live and on-demand courses focused on the understanding of the science, business, and regulatory practices essential to the biopharma and medical device sectors for 20 years. Our industry experts design and deliver the most current, insightful, and engaging instruction available anywhere.

We empower those in biopharma and medical device companies to make prudent strategic business decisions, navigate significant regulatory hurdles, and move healthcare products from the bench to the bedside by increasing their understanding of how each part influences the other.

Questions? Contact us at info@biotechprimer.com